Literature DB >> 19763056

Early postoperative recovery by chronic dialysis patients after coronary artery bypass grafting.

Junko Kobayashi1, Masahiko Ikebuchi, Yasufumi Fujita, Hiroyuki Irie.   

Abstract

OBJECTIVE: A faster start at rehabilitation has been a great benefit in reducing complications and costs after coronary artery bypass grafting (CABG). We studied early postoperative recovery from CABG in dialysis patients.
METHODS: From January 2001 to May 2006, a total of 401 patients underwent isolated CABG at our institution. We retrospectively studied 348 consecutive elective cases, which were divided into two groups; 18 with dialysis (group D) and 330 without dialysis (group N), with respect to having meals, standing, and walking.
RESULTS: An analysis of patient demographics revealed significant differences in gender, comorbidity of old cerebral infarction, anemia, and water balance during operation (P <0.05). Operative and in-hospital mortalities were 0% in group D. The percentages of the patients who were eating meals, standing, or walking on postoperative day (POD) 1 in group D were 88.9%, 66.6%, and 27.8%, respectively. In group N, these percentages were significantly higher: 96.1%, 85.5%, and 75.8%. But by POD 2, these values became similar. We considered that the delay of rehabilitation in group D was mainly due to hemodialysis on POD 1.
CONCLUSION: Early postoperative recovery from elective isolated CABG in dialysis patients delayed a day against nondialysis patients. The delay was considered a result of the inevitable dialysis on POD 1.

Entities:  

Mesh:

Year:  2009        PMID: 19763056

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  1 in total

1.  Comparing cardiac surgery in peritoneal dialysis and hemodialysis patients: perioperative outcomes and two-year survival.

Authors:  Victoria A Kumar; Shubha Ananthakrishnan; Scott A Rasgon; Eric Yan; Raoul Burchette; Karen Dewar
Journal:  Perit Dial Int       Date:  2011-09-30       Impact factor: 1.756

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.